Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anesiva, Inc.
Anesiva Announces Changes to Its Board of Directors and Receives Notification From Nasdaq
January 9th, 2009
Anesiva, Inc. (NASDAQ:ANSV), a specialty pain management company, announced that consistent with its recent announcement of a positive Phase 3 clinical trial for Adlea(TM) and to focus on this asset by going to a virtual company model, five members of the company's Board of Directors have resigned, reducing the number of Directors to five. The Board accepted the resignations of Thomas J. Colligan, Carter H. Eckert, James A. Harper and Robert L. Zerbe from the Anesiva Board of Directors on December 16, 2008. The Board accepted the resignation of James N. Campbell on December 19, 2008. Mr. Colligan's and Mr. Eckert's resignations reduced the number of members of the Audit...
Source: Health Business Week (2009-01-09)
|
